Results 1 to 10 of about 242,368 (323)
Clinical course of COPD in patients with Arg16Gly (rs1042713) polymorphism of ADRB2 gene
Monaldi Archives for Chest Disease, 2022 The ADBR2 gene has been studied for its possible relationship with the development and clinical course of chronic obstructive pulmonary disease (COPD), including response to beta-2 agonists, with existing data being contentious on the subject.
Kostiantyn Dmytriiev +3 more
doaj +1 more source
Frontiers in Pediatrics, 2022 BackgroundThe aim of this study was to determine the differences in the characteristics of Mycoplasma pneumoniae pneumonia (MPP) in children with and without asthma and in children with asthma with and without inhaled corticosteroid (ICS) therapy in ...
Bing Wei +3 more
doaj +1 more source
Immunomodulatory regulator blockade in a viral exacerbation model of severe asthma
Frontiers in Immunology, 2022 Asthmatics are more susceptible to viral infections than healthy individuals and are known to have impaired innate anti-viral defences. Influenza A virus causes significant morbidity and mortality in this population.
Ben Nicholas +6 more
doaj +1 more source
Frontiers in Rehabilitation Sciences, 2022 BackgroundExacerbations affect the disease trajectory of patients with COPD and result in an acute drop of functional status and physical activity. Timely detection of exacerbations by non-medical healthcare professionals is needed to counteract this ...
Astrid Blondeel +9 more
doaj +1 more source
Key toolkits of non-pharmacological management in COPD: during and beyond COVID-19
Frontiers in Bioscience-Landmark, 2021 Individuals with COPD are at higher risk of severe disease and mortality if they contract COVID-19. Shielding and social distancing have negatively impacted the delivery of routine care for COPD patients, which should be maintained to avoid further ...
Jaber S. Alqahtani +4 more
doaj +1 more source
Decline of COPD exacerbations in clinical trials over two decades -- a systematic review and meta-regression [PDF]
Respiratory Research 20:186, 2019, 2019 BACKGROUND: An important goal of chronic obstructive pulmonary disease (COPD) treatment is to reduce the frequency of exacerbations. Some observations suggest a decline in exacerbation rates in clinical trials over time. A more systematic understanding would help to improve the design and interpretation of COPD trials.
arxiv +1 more source
Addictive Behaviors Reports, 2023 Background and Aims: Medications for opioid use disorder (MOUD) are highly effective in improving treatment outcomes and reducing overdose. Concerns about interrupted access to critical MOUD services led to expansion of telemedicine services during the ...
Mollie A. Monnig +6 more
doaj
International Journal of COPD, 2021 Jia Yang,1 Junchao Yang2 1The First Clinical College, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical ...
Yang J, Yang J
doaj
International Journal of COPD, 2021 Yi-Jen Huang,1,2 Senyeong Kao,1,3 Li-Ting Kao,1,3– 5 Chih-Feng Chian,6 Chi-Hsiang Chung,3,7 Wu-Chien Chien,1,3,7,* Kwua-Yun Wang1,8,9,* 1Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan; 2Department of Nursing ...
Huang YJ +6 more
doaj
International Journal of COPD, 2021 Qing Song,1– 3 Yi-Yang Zhao,1– 3 Yu-Qin Zeng,1– 3 Cong Liu,1– 3 Wei Cheng,1– 3 Min-Hua Deng,4 Xin Li,5 Li-Bing Ma,6 Yan Chen,1– 3 Shan Cai,1– 3 Ping Chen1– 3 1Department of Respiratory and Critical Care ...
Song Q +10 more
doaj